161 related articles for article (PubMed ID: 26112867)
21. [Microalbuminuria and left ventricular geometry in essential arterial hypertension].
Lakhdhar R; Jarraya F; Drissa H; Hachicha J; Kammoun S
Tunis Med; 2009 Feb; 87(2):111-4. PubMed ID: 19522442
[TBL] [Abstract][Full Text] [Related]
22. Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
Kim Y; Cho JS; Cho WK; Yoon HE; Hong YA; Chang YK; Yang CW; Kim SY; Hwang HS
Int J Cardiol; 2017 Dec; 249():372-376. PubMed ID: 29121742
[TBL] [Abstract][Full Text] [Related]
23. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age.
Palatini P; Mos L; Santonastaso M; Saladini F; Benetti E; Mormino P; Bortolazzi A; Cozzio S
J Womens Health (Larchmt); 2011 Aug; 20(8):1175-81. PubMed ID: 21702688
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
[TBL] [Abstract][Full Text] [Related]
25. Severe visual loss caused by unrecognized malignant hypertension in a 15-year-old girl.
Cortina G; Hofer J; Giner T; Jungraithmayr T
Pediatr Int; 2015 Apr; 57(2):e42-4. PubMed ID: 25868960
[TBL] [Abstract][Full Text] [Related]
26. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C;
Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension.
Iwashima Y; Horio T; Kamide K; Rakugi H; Ogihara T; Kawano Y
Hypertens Res; 2007 Dec; 30(12):1177-85. PubMed ID: 18344622
[TBL] [Abstract][Full Text] [Related]
28. Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Nadar SK; Tayebjee MH; Messerli F; Lip GY
Curr Pharm Des; 2006; 12(13):1581-92. PubMed ID: 16729871
[TBL] [Abstract][Full Text] [Related]
29. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
30. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
[TBL] [Abstract][Full Text] [Related]
31. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
[TBL] [Abstract][Full Text] [Related]
33. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular target organ damage could have been detected in sustained pediatric hypertension.
Meng L; Hou D; Zhao X; Hu Y; Liang Y; Liu J; Yan Y; Mi J
Blood Press; 2015; 24(5):284-92. PubMed ID: 26024395
[TBL] [Abstract][Full Text] [Related]
35. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience.
Hitha B; Pappachan JM; Pillai HB; Sujathan P; Ramakrishna CD; Jayaprakash K; Raihanathul Misiriya KJ
Saudi J Kidney Dis Transpl; 2008 May; 19(3):411-9. PubMed ID: 18445902
[TBL] [Abstract][Full Text] [Related]
36. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
38. [Incidence and risk factors of target organ damage in 17, 682 elderly hypertensive inpatients between 1993 and 2008].
Cui H; Fan L; Zhang M; Ye P; Dai W; Liu GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Apr; 40(4):307-12. PubMed ID: 22801309
[TBL] [Abstract][Full Text] [Related]
39. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
40. Mild Hypertensive Retinopathy and Risk of Cardiovascular Disease: The Suita Study.
Li J; Kokubo Y; Arafa A; Sheerah HA; Watanabe M; Nakao YM; Honda-Kohmo K; Kashima R; Sakai Y; Watanabe E; Teramoto M; Dohi T; Koga M
J Atheroscler Thromb; 2022 Nov; 29(11):1663-1671. PubMed ID: 35034920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
